MRLSX
Price
$18.48
Change
-$0.33 (-1.75%)
Updated
Jun 13 closing price
Net Assets
131.09M
RGEBX
Price
$74.89
Change
-$0.91 (-1.20%)
Updated
Jun 13 closing price
Net Assets
306.22B
Interact to see
Advertisement

MRLSX vs RGEBX

Header iconMRLSX vs RGEBX Comparison
Open Charts MRLSX vs RGEBXBanner chart's image
AMG Renaissance Large Cap Growth I
Price$18.48
Change-$0.33 (-1.75%)
VolumeN/A
Net Assets131.09M
American Funds Growth Fund of Amer R2E
Price$74.89
Change-$0.91 (-1.20%)
VolumeN/A
Net Assets306.22B
MRLSX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MRLSX vs. RGEBX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRLSX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 306B vs. MRLSX (131M). MRLSX (0.00) and RGEBX (0.00) have matching dividends . MRLSX was incepted earlier than RGEBX: MRLSX (16 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than MRLSX (0.84). MRLSX is a more actively managed with annual turnover of: 47.00 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than MRLSX: RGEBX (250) vs MRLSX (100000). RGEBX annual gain was more profitable for investors over the last year : 7.68 vs. MRLSX (0.54). RGEBX (45.42) and MRLSX (44.37) have equivalent 5 years return.
MRLSXRGEBXMRLSX / RGEBX
Total Expense Ratio0.731.0967%
Annual Report Gross Expense Ratio0.841.0977%
Fund Existence16 years11 years-
Gain YTD1.5944.82933%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets131M306B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year0.547.687%
Returns for 3 years29.1751.0157%
Returns for 5 years44.3745.4298%
Returns for 10 years61.7265.8794%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APGE44.482.62
+6.26%
Apogee Therapeutics
VVOS2.140.01
+0.47%
Vivos Therapeutics
SJM95.72-1.65
-1.69%
JM Smucker Company (The)
ELVA3.38-0.17
-4.79%
Electrovaya
NNDM1.44-0.12
-7.69%
Nano Dimension Ltd